These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 23770334

  • 1. Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination.
    Mahamud A, Masunu-Faleafaga Y, Walls L, Williams N, Garcia P, Teshale E, Williams R, Dulski T, Bellini WJ, Kutty PK.
    Vaccine; 2013 Aug 12; 31(36):3683-7. PubMed ID: 23770334
    [Abstract] [Full Text] [Related]

  • 2. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Aug 12; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 3. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231
    [Abstract] [Full Text] [Related]

  • 4. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, Balicer RD.
    Hum Vaccin Immunother; 2015 Jun 14; 11(6):1400-5. PubMed ID: 25891446
    [Abstract] [Full Text] [Related]

  • 5. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS.
    Viral Immunol; 2016 Apr 14; 29(3):159-63. PubMed ID: 26910764
    [Abstract] [Full Text] [Related]

  • 6. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í, Köse Ş, Akbulut Í, Albayrak H.
    Rev Esp Quimioter; 2019 Dec 14; 32(6):525-531. PubMed ID: 31642641
    [Abstract] [Full Text] [Related]

  • 7. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 8. Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.
    Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V.
    BMC Infect Dis; 2024 Jul 12; 24(1):696. PubMed ID: 38997625
    [Abstract] [Full Text] [Related]

  • 9. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan 12; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 10. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N, Altawalah H, Alfouzan W, Al-Nakib W, Al-Roumi E, Jeragh A.
    J Med Virol; 2020 Aug 12; 92(8):963-970. PubMed ID: 31919861
    [Abstract] [Full Text] [Related]

  • 11. Measles, mumps, rubella and varicella antibodies among international and domestic university students.
    Dyda A, Broome A, Rawlinson W, Mahimbo A, Saha A, Kefalas B, Seale H, Macintyre CR, Zwar N, Gidding HF, Heywood AE.
    J Travel Med; 2024 Jan 28; 31(1):. PubMed ID: 38195239
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
    Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho RK, Kumar R.
    Indian J Med Res; 2019 Mar 28; 149(3):396-403. PubMed ID: 31249206
    [Abstract] [Full Text] [Related]

  • 13. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL, Castaneda D, Arellano Quintanilla DM, Martínez D, Trumbo SP, Fernández de Castro J.
    Vaccine; 2017 May 25; 35(23):3116-3122. PubMed ID: 28457672
    [Abstract] [Full Text] [Related]

  • 14. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530
    [Abstract] [Full Text] [Related]

  • 15. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M, Berginc N.
    Wien Klin Wochenschr; 2008 May 07; 120(13-14):422-6. PubMed ID: 18726668
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
    Chaiwarith R, Praparattanapan J, Nuket K, Kotarathitithum W, Supparatpinyo K.
    BMC Infect Dis; 2016 Apr 30; 16():190. PubMed ID: 27138005
    [Abstract] [Full Text] [Related]

  • 17. Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K.
    MMWR Morb Mortal Wkly Rep; 2022 Nov 18; 71(46):1465-1470. PubMed ID: 36395065
    [Abstract] [Full Text] [Related]

  • 18. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ, Li Q, Yan R, Zhou Y, Tang XW, Deng X, Xie SY, Chen ZP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr 06; 51(4):336-340. PubMed ID: 28395468
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.